Therapy Areas: Autoimmune
Biller Named to Rome Therapeutics Board of Directors
2 March 2021 - - US-based biotechnology company Rome Therapeutics has appointed Scott Biller, Ph.D., to the Rome board of directors, the company said.

A chemist by training, Dr. Biller ha...
Zhang Named Chief Medical Officer at InnoCare
1 March 2021 - - China-based biopharmaceutical company InnoCare Pharma (HKEX: 09969) has appointed Dr. Sean Zhang as chief medical officer, the company said.

Reporting to the Co-founder, ...
Jubilant Therapeutics collaborates with Boston Children's Hospital
26 February 2021 - Jubilant Therapeutics Inc, a biopharmaceutical company, has collaborated with Boston Children's Hospital to assess peptidyl arginine deiminase 4 (PAD4) inhibitors under develop...
Jaguar Gene Therapy Launches with Goal of Accelerating Breakthroughs in Gene Therapy for Patients Suffering from Severe Genetic Diseases
25 February 2021 - - US-based gene therapies developer Jaguar Gene Therapy has launched after being in stealth mode for the past year and is uniquely positioned to accelerate gene therapy develop...
Xencor Teams with UCLA to Discover and Develop Novel XmAb Therapeutics
25 February 2021 - - US-based biopharmaceutical company Xencor, Inc. (NASDAQ: XNCR) and UCLA Technology Development Group (UCLA TDG) have inked an agreement to develop novel therapeutic...
Metagenomi Adds Immuno-oncology Clinical Research Experts to its Scientific Advisory Board
24 February 2021 - - US-based gene editing and cell and gene therapy company Metagenomi has added three experts in immuno-oncology clinical and basic research from Fred Hutchinson Cancer Research Cent...